Not Intended for Therapeutic Use. For research use only.

MMAF Hydrochloride - CAS 1415246-68-2

Quick Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Category
ADCs
Product Name
MMAF Hydrochloride
Catalog Number
1415246-68-2
Synonyms
Monomethylauristatin F Hcl
CAS Number
1415246-68-2
Description
Monomethylauristatin F Hcl(MMAF Hcl) is an antitubulin agent that inhibit cell division by blocking the polymerization of tubulin; lower cytotoxic activity than MMAE; antibody drug cytotoxin.
Molecular Weight
768.42
Molecular Formula
C39H66ClN5O8
COA
Inquire
MSDS
Inquire
Tag
ADCs Cytotoxin
Structure
CAS 1415246-68-2 MMAF Hydrochloride
Specification
Purity
>98%
Application
ADCs Cytotoxin
Related ADCs Cytotoxin Products
  • CAS 17946-87-1 Leucomisine

    Leucomisine
    (CAS: 17946-87-1)

    Sesquiterpene lactone , from plants of the Compositae family, an antiatherosclerotic, angioprotective, hypolipidemic and anti-inflammatory.

  • CAS 11033-64-0 N-deacetyllappaconitine

    N-deacetyllappaconitine
    (CAS: 11033-64-0)

    A diterpenoid alkaloids from plants of the Aconitum and Delphinium species, selective blocker of the TTX-sensitive Na+ channel in the heart; potent antiarrhythm...

  • Adaphotris
    (CAS: )

    Inhibitor of Ca2+/2H+-exchange system in liver mitochondria. , synthetic.

  • Seco-DuocarmycinDMG
    (CAS: 1613286-55-7)

    Seco-Duocarmycin DMG is a cytotoxic agent, used as the cytotoxic component in antibody-drug conjugates.

  • CAS 80-12-6 TETS

    TETS
    (CAS: 80-12-6)

    Synthetic, GABAA-gated Cl- channels blocker; non-competitive GABAA antagonist.

  • CAS 32908-73-9 MCD Peptide

    MCD Peptide
    (CAS: 32908-73-9)

    22-amino acid peptide with a strongly basic character and 2 disulfide bridges, , from Apis mellifera bee venom, a blocker of voltage-sensitive K+ channels with ...

  • Lqh III
    (CAS: 212134-01-5)

    A scorpion alpha-insect toxin, which prolongs the evoked action potential by an inhibition of sodium current inactivation in insects and mammals.

  • CAS 99815-83-5 Nudicauline Perchlorate

    Nudicauline Perchlorate
    (CAS: 99815-83-5)

    Nudicauline is extracted from plants of the Ranunculaceae family, a Alpha-Bungarotoxin neuronal nicotinic receptor.

  • CAS 163768-50-1 Auristatin F

    Auristatin F
    (CAS: 163768-50-1)

    Auristatin F is a cytotoxic tubulin modifier with potent and selective antitumor activity; MMAF analog and cytotoxin in Antibody-drug conjugates.

  • CAS 19918-85-5 Diplacine

    Diplacine
    (CAS: 19918-85-5)

    Diplacine is a nicotinic cholinoreceptor antagonist at the neuromuscular junction.

  • CAS 78111-14-5 MEOA

    MEOA
    (CAS: 78111-14-5)

    A methyl easter of Okadaic acid. Okadaic acid is a marine sponge toxin which potently inhibits certain serine/threonine protein phosphatases.

  • CAS 7348-26-7 Oxylidin

    Oxylidin
    (CAS: 7348-26-7)

    Synthetic, a weak AChR antagonist.

  • Allochroside
    (CAS: 141489-39-6)

    a non specific stimulant of immunogenesis; also used for erytrocytes hemolysis and automatic leucocyte numbering. Triterpene saponine, mixture of 4 glycosides f...

  • CAS 45651-41-0 Q Me

    Q Me
    (CAS: 45651-41-0)

    Synthetic, nicotinic AChR. Rigid bicyclic analog of TMA and TEA.

  • CAS 14140-18-2 Trachelanthamine

    Trachelanthamine
    (CAS: 14140-18-2)

    Known as a weak hypotensive, moderate M- and N-cholinolytic pyrrolizidine alkaloid, xtracted from Trachelanthus Korolkowia.

  • CAS 58-08-2 Caffeine

    Caffeine
    (CAS: 58-08-2)

    a CNS stimulant. Alkaloid, , purified from plants of Coffea genus, Rubiaceae.

  • CAS 12778-32-4 β-Bungarotoxin

    β-Bungarotoxin
    (CAS: 12778-32-4)

    β-Bungarotoxin is a form of bungarotoxin that is fairly common in Krait (Bungaros multicinctus) venoms. A pre-synaptic toxin with enzymatic activity.

  • (-)-Scopolamine Perchlorate
    (CAS: )

    Scopolamine, a nonselective muscarinic receptor antagonist, induces distinct behaviors of attenuated motility and C-like hyperactivity.

  • CAS 126-17-0 Solasodine

    Solasodine
    (CAS: 126-17-0)

    Solasodine(Purapuridine) is a poisonous alkaloid chemical compound that occurs in plants of the Solanaceae family. Solasodine showed selective cytotoxicity agai...

  • Dihydroatisine HCl
    (CAS: )

    An antiarrhythmic of 1-st and 1Y classes and a blocker of TTX sensitive Na+ channels, Ca++ antagonist diterpene alkaloid from Delphinium staphisagria.

Reference Reading
1. Emerging classes of armed antibody therapeutics against cancer
Christian Hess, Dario Venetz, Dario Neri*. Med. Chem. Commun.,2014, 5,408–431
Calicheamicins bind to the DNA minor groove where they induce double-strand breaks leading to chromosomal disruption, ultimately resulting in programmed cell death, while the other two drugs interfere with microtubule restructuring. Auristatins were originally derived from the naturally occurring pentapeptide dolastatin-10. Mono-methyl auristatin E (MMAE) and F (MMAF) are the most prominent dolastatin-10 derivatives, which are implemented in many current clinical-stage ADCs. These fully synthetic analogues differ from natural dolastatin-10 in terms of an N-terminal methyl group, which results in superior proteolytic stability. Additionally, MMAF features a C-terminal charged phenylalanine residue, which attenuates its cytotoxic activity compared to the uncharged MMAE. Maytansinoids such as DM1 and DM4 are derivatives of the natural product maytansine and represent two of the most widely used ADC payloads to date. Upon lysosomal degradation of the antibody, the mechanism of action of these two agents is considered to be identical. However, the linker region of the drug can have a profound impact on ADC performance. It has been reported for disulfide-linked maytansinoids that two additional methyl groups at positions directly adjacent to the disulfide bond (corresponding to DM4) can increase plasma stability of the conjugate.
2. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics
Hans-Peter Gerber, Frank E. Koehnb, Robert T. Abraham*. Nat. Prod. Rep., 2013, 30, 625–639
An additional clinically-relevant auristatin, MMAF, bears a C-terminated phenylalanine residue with a free carboxyl group. MMAF proved effective in preclinical models of Hodgkin's lymphoma and anaplastic large cell lymphoma (ALCL) when conjugated to anti-CD30 antibodies and has now been conjugated to additional antibodies with non-cleavable linkers. Themaleimidocaproyl (MalC) linker is used in SGN-75 of Seattle Genetics to conjugate MMAF to an anti-CD70 antibody. Once in the lysosome, the antibody is degraded to yield the MMAF-caproylmaleido-cysteine adduct as the active cyto-Toxin. Due to its free carboxyl group, MMAF itself has limited cell permeability, and its in vitro potency is roughly 10–200-fold lower than that of the MMAE. However, these shortcomings are effectively overcome by transfer to the ADC format, which effectively delivers the payload intracellularly, leading to a potency increase of 2200-fold as well as reduced toxicity against non-antigen-expressing cells.
2005 - BOC Sciences | All rights reserved
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
DOWNLOAD